Albumin
From Proteopedia
(Difference between revisions)
| Line 11: | Line 11: | ||
The binding mode of <scene name='Journal:JBSD:26/Cv/2'>erlotinib hydrochloride (ET)</scene>, a targeted anticancer drug, to <scene name='Journal:JBSD:26/Cv/8'>bovine serum albumin (BSA)</scene> was investigated through 1H NMR, spectroscopic, thermodynamic and molecular modeling methods. Each subdomain is marked with a different colour (<font color='red'><b>red for subdomain IA</b></font>; <span style="color:orange;background-color:black;font-weight:bold;">orange, IB</span>; <span style="color:cyan;background-color:black;font-weight:bold;">cyan, IIA</span>; <span style="color:yellow;background-color:black;font-weight:bold;">yellow, IIB</span>; <span style="color:lime;background-color:black;font-weight:bold;">green, IIIA</span>; <font color='darkmagenta'><b>darkmagenta, IIIB</b></font>). From these methods, the binding parameters, binding site, binding distance, and conformational changes were obtained. Site marker competitive experiments demonstrated that the <scene name='Journal:JBSD:26/Cv/6'>binding site was located in the hydrophobic pocket of site I (subdomain IIA)</scene>. The docking modeling agreed with the results of the fluorescence and displacement experiments. | The binding mode of <scene name='Journal:JBSD:26/Cv/2'>erlotinib hydrochloride (ET)</scene>, a targeted anticancer drug, to <scene name='Journal:JBSD:26/Cv/8'>bovine serum albumin (BSA)</scene> was investigated through 1H NMR, spectroscopic, thermodynamic and molecular modeling methods. Each subdomain is marked with a different colour (<font color='red'><b>red for subdomain IA</b></font>; <span style="color:orange;background-color:black;font-weight:bold;">orange, IB</span>; <span style="color:cyan;background-color:black;font-weight:bold;">cyan, IIA</span>; <span style="color:yellow;background-color:black;font-weight:bold;">yellow, IIB</span>; <span style="color:lime;background-color:black;font-weight:bold;">green, IIIA</span>; <font color='darkmagenta'><b>darkmagenta, IIIB</b></font>). From these methods, the binding parameters, binding site, binding distance, and conformational changes were obtained. Site marker competitive experiments demonstrated that the <scene name='Journal:JBSD:26/Cv/6'>binding site was located in the hydrophobic pocket of site I (subdomain IIA)</scene>. The docking modeling agreed with the results of the fluorescence and displacement experiments. | ||
| + | |||
| + | == 3D Structures of albumin == | ||
| + | [[Albumin 3D structures]] | ||
| + | |||
</StructureSection> | </StructureSection> | ||
| Line 20: | Line 24: | ||
*Human serum albumin | *Human serum albumin | ||
| - | **[[1e78]], [[1bm0]], [[1ao6]], [[1uor]], [[3sqj]], [[4g03]], [[4g04]], [[4k2c]] - hSA – human | + | **[[1e78]], [[1bm0]], [[1ao6]], [[1uor]], [[3sqj]], [[4g03]], [[4g04]], [[4k2c]], [[5z0b]] - hSA – human |
*Human serum albumin binary complex | *Human serum albumin binary complex | ||
| Line 26: | Line 30: | ||
**[[2ydf]] – hSA + iophenoxic acid<br /> | **[[2ydf]] – hSA + iophenoxic acid<br /> | ||
**[[2xvq]], [[2xvu]], [[2xw0]], [[2xw1]] - hSA + dansyl derivative<br /> | **[[2xvq]], [[2xvu]], [[2xw0]], [[2xw1]] - hSA + dansyl derivative<br /> | ||
| - | **[[3lu6]], [[3ju7]], [[3lu8]], [[2bx8]], [[2bxa]], [[2bxb]], [[2bxc]], [[2bxd]], [[2bxe]], [[2bxf ]], [[2bxg]], [[2bxh]], [[2bxi]], [[2bxk]], [[2bxl]], [[2bxm]], [[2bxn]],[[2bxo]], [[2bxp]], [[2bxq]], [[3lu7]], [[4l8u]], [[4l9k]], [[4l9q]], [[4la0]], [[4lb2]], [[4lb9]], [[5ifo]], [[5id9]], [[5id7]], [[5gix]], [[5giy]] – hSA + drug<br /> | + | **[[3lu6]], [[3ju7]], [[3lu8]], [[2bx8]], [[2bxa]], [[2bxb]], [[2bxc]], [[2bxd]], [[2bxe]], [[2bxf ]], [[2bxg]], [[2bxh]], [[2bxi]], [[2bxk]], [[2bxl]], [[2bxm]], [[2bxn]],[[2bxo]], [[2bxp]], [[2bxq]], [[3lu7]], [[4l8u]], [[4l9k]], [[4l9q]], [[4la0]], [[4lb2]], [[4lb9]], [[5ifo]], [[5id9]], [[5id7]], [[5gix]], [[5giy]], [[5yb1]] – hSA + drug<br /> |
**[[4iw1]], [[4iw2]] – hSA + monosaccharide<br /> | **[[4iw1]], [[4iw2]] – hSA + monosaccharide<br /> | ||
**[[3jqz]] – hSA + lidocaine<br /> | **[[3jqz]] – hSA + lidocaine<br /> | ||
| Line 47: | Line 51: | ||
**[[4hgk]], [[4hgm]], [[5fuo]] – hSA + shark antibody<br /> | **[[4hgk]], [[4hgm]], [[5fuo]] – hSA + shark antibody<br /> | ||
**[[5vnw]] – hSA + nanobody<br /> | **[[5vnw]] – hSA + nanobody<br /> | ||
| + | **[[6a7p]] – hSA + apipiprazole<br /> | ||
*Human serum albumin ternary complex | *Human serum albumin ternary complex | ||
| Line 72: | Line 77: | ||
**[[3v03]], [[4f5s]] - bSA – bovine<br /> | **[[3v03]], [[4f5s]] - bSA – bovine<br /> | ||
| + | **[[4jk4]] – bSA + diiodosalicilate<br /> | ||
| + | **[[4or0]] – bSA + drug<br /> | ||
**[[3v08]], [[4f5t]], [[4f5u]], [[5hoz]] – hoSA – horse<br /> | **[[3v08]], [[4f5t]], [[4f5u]], [[5hoz]] – hoSA – horse<br /> | ||
| + | **[[6mdq]] – hoSA + testosterone<br /> | ||
| + | **[[4j2v]] – hoSA + diiodosalicilate<br /> | ||
| + | **[[4ot2]], [[5dqf]], [[5dby]], [[4zbr]], [[4zbq]], [[5v0v]], [[6ci6]] – hoSA + drug<br /> | ||
**[[3v09]], [[4f5v]] – rSA – rabbit<br /> | **[[3v09]], [[4f5v]] – rSA – rabbit<br /> | ||
| + | **[[4po0]] – rSA + drug<br /> | ||
**[[4luf]], [[5orf]] – sSA – sheep<br /> | **[[4luf]], [[5orf]] – sSA – sheep<br /> | ||
| + | **[[4luh]] – sSA + diiodosalicilate<br /> | ||
**[[5ori]], [[5otb]] – gSA – goat<br /> | **[[5ori]], [[5otb]] – gSA – goat<br /> | ||
| + | **[[5osw]] – gSA + diiodosalicilate<br /> | ||
**[[3vvj]] – SA – emu<br /> | **[[3vvj]] – SA – emu<br /> | ||
**[[5ghk]] – SA – dog<br /> | **[[5ghk]] – SA – dog<br /> | ||
| - | **[[ | + | **[[5yxe]] – SA - cat<br /> |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
*Albumin | *Albumin | ||
| Line 95: | Line 101: | ||
**[[3lp9]] – Alb hemopexin domain – ''Lathyrus sativus''<br /> | **[[3lp9]] – Alb hemopexin domain – ''Lathyrus sativus''<br /> | ||
**[[2lvf]] – Alb – Brazil nut<br /> | **[[2lvf]] – Alb – Brazil nut<br /> | ||
| - | **[[5dom]] – | + | **[[5dom]] – Alb 2S – horseradish tree<br /> |
**[[5okl]] – ha-Alb<br /> | **[[5okl]] – ha-Alb<br /> | ||
| + | **[[6fak]] – h-α-Alb<br /> | ||
}} | }} | ||
'''References''' | '''References''' | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 07:44, 4 March 2019
| |||||||||||
3D Structures of albumin
Updated on 04-March-2019
References
- ↑ Liu Y, Chen M, Luo Z, Lin J, Song L. Investigation on the site-selective binding of bovine serum albumin by erlotinib hydrochloride. J Biomol Struct Dyn. 2012 Oct 17. PMID:23072300 doi:10.1080/07391102.2012.726532
